157 related articles for article (PubMed ID: 10507600)
1. Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients.
García-Garmendia JL; Ortiz-Leyba C; Garnacho-Montero J; Jiménez-Jiménez FJ; Monterrubio-Villar J; Gili-Miner M
Crit Care Med; 1999 Sep; 27(9):1794-9. PubMed ID: 10507600
[TBL] [Abstract][Full Text] [Related]
2. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.
Pittet D; Tarara D; Wenzel RP
JAMA; 1994 May; 271(20):1598-601. PubMed ID: 8182812
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and Outcomes of Acinetobacter baumannii Infections in Critically Ill Patients with Cancer: A Matched Case-Control Study.
Nazer LH; Kharabsheh A; Rimawi D; Mubarak S; Hawari F
Microb Drug Resist; 2015 Oct; 21(5):556-61. PubMed ID: 26430944
[TBL] [Abstract][Full Text] [Related]
4. Cost of intensive care unit-acquired bloodstream infections.
Laupland KB; Lee H; Gregson DB; Manns BJ
J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
[TBL] [Abstract][Full Text] [Related]
5. Nosocomial infections in the medical ICU: a retrospective study highlighting their prevalence, microbiological profile and impact on ICU stay and mortality.
Pradhan NP; Bhat SM; Ghadage DP
J Assoc Physicians India; 2014 Oct; 62(10):18-21. PubMed ID: 25906516
[TBL] [Abstract][Full Text] [Related]
6. [Infections caused by Acinetobacter spp. in critically ill ICU patients].
Alvarez-Lerma F; Palomar M; Insausti J; Olaechea P; Cerdá E; Castillo F; Martínez-Pellús A;
Enferm Infecc Microbiol Clin; 2005 Nov; 23(9):533-9. PubMed ID: 16324565
[TBL] [Abstract][Full Text] [Related]
7. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study.
Blot S; Vandewoude K; Colardyn F
Intensive Care Med; 2003 Mar; 29(3):471-5. PubMed ID: 12577148
[TBL] [Abstract][Full Text] [Related]
8. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study.
Soufir L; Timsit JF; Mahe C; Carlet J; Regnier B; Chevret S
Infect Control Hosp Epidemiol; 1999 Jun; 20(6):396-401. PubMed ID: 10395140
[TBL] [Abstract][Full Text] [Related]
9. Excess mortality due to pandrug-resistant Acinetobacter baumannii infections in hospitalized patients.
Karakonstantis S; Gikas A; Astrinaki E; Kritsotakis EI
J Hosp Infect; 2020 Nov; 106(3):447-453. PubMed ID: 32927013
[TBL] [Abstract][Full Text] [Related]
10. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences.
Playford EG; Craig JC; Iredell JR
J Hosp Infect; 2007 Mar; 65(3):204-11. PubMed ID: 17254667
[TBL] [Abstract][Full Text] [Related]
11. Estimating attributable mortality due to nosocomial infections acquired in intensive care units.
Januel JM; Harbarth S; Allard R; Voirin N; Lepape A; Allaouchiche B; Guerin C; Lehot JJ; Robert MO; Fournier G; Jacques D; Chassard D; Gueugniaud PY; Artru F; Petit P; Robert D; Mohammedi I; Girard R; Cêtre JC; Nicolle MC; Grando J; Fabry J; Vanhems P
Infect Control Hosp Epidemiol; 2010 Apr; 31(4):388-94. PubMed ID: 20156064
[TBL] [Abstract][Full Text] [Related]
12. Morbidity and mortality associated with primary and catheter-related bloodstream infections in critically ill patients.
Olaechea PM; Palomar M; Álvarez-Lerma F; Otal JJ; Insausti J; López-Pueyo MJ;
Rev Esp Quimioter; 2013 Mar; 26(1):21-9. PubMed ID: 23546458
[TBL] [Abstract][Full Text] [Related]
13. Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis.
van Vught LA; Klein Klouwenberg PM; Spitoni C; Scicluna BP; Wiewel MA; Horn J; Schultz MJ; Nürnberg P; Bonten MJ; Cremer OL; van der Poll T;
JAMA; 2016 Apr; 315(14):1469-79. PubMed ID: 26975785
[TBL] [Abstract][Full Text] [Related]
14. ICU-associated Acinetobacter baumannii colonisation/infection in a high HIV-prevalence resource-poor setting.
Ntusi NB; Badri M; Khalfey H; Whitelaw A; Oliver S; Piercy J; Raine R; Joubert I; Dheda K
PLoS One; 2012; 7(12):e52452. PubMed ID: 23300673
[TBL] [Abstract][Full Text] [Related]
15. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients.
Cook DJ; Griffith LE; Walter SD; Guyatt GH; Meade MO; Heyland DK; Kirby A; Tryba M;
Crit Care; 2001 Dec; 5(6):368-75. PubMed ID: 11737927
[TBL] [Abstract][Full Text] [Related]
16. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
Ferrando C; Mellado-Artigas R; Gea A; Arruti E; Aldecoa C; Bordell A; Adalia R; Zattera L; Ramasco F; Monedero P; Maseda E; Martínez A; Tamayo G; Mercadal J; Muñoz G; Jacas A; Ángeles G; Castro P; Hernández-Tejero M; Fernandez J; Gómez-Rojo M; Candela Á; Ripollés J; Nieto A; Bassas E; Deiros C; Margarit A; Redondo FJ; Martín A; García N; Casas P; Morcillo C; Hernández-Sanz ML;
Rev Esp Anestesiol Reanim (Engl Ed); 2020 Oct; 67(8):425-437. PubMed ID: 32800622
[TBL] [Abstract][Full Text] [Related]
17. Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit.
Holloway KP; Rouphael NG; Wells JB; King MD; Blumberg HM
Ann Pharmacother; 2006 Nov; 40(11):1939-45. PubMed ID: 17018688
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients.
Trottier V; Namias N; Pust DG; Nuwayhid Z; Manning R; Marttos AC; Dunham MB; Schulman CI; McKenney MG
Surg Infect (Larchmt); 2007 Aug; 8(4):437-43. PubMed ID: 17883360
[TBL] [Abstract][Full Text] [Related]
19. An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients.
Fierobe L; Lucet JC; Decré D; Muller-Serieys C; Deleuze A; Joly-Guillou ML; Mantz J; Desmonts JM
Infect Control Hosp Epidemiol; 2001 Jan; 22(1):35-40. PubMed ID: 11198020
[TBL] [Abstract][Full Text] [Related]
20. Attributable mortality of nosocomial Acinetobacter bacteremia.
Grupper M; Sprecher H; Mashiach T; Finkelstein R
Infect Control Hosp Epidemiol; 2007 Mar; 28(3):293-8. PubMed ID: 17326019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
